Multiple Myeloma Mechanism of Action

Pharmacology of Carmustine (Bicnu) ; Overview, Pharmacokinetics, Mechanism of action, Uses, EffectsПодробнее

Pharmacology of Carmustine (Bicnu) ; Overview, Pharmacokinetics, Mechanism of action, Uses, Effects

Overcoming T-cell exhaustion to improve CAR-T efficacy in multiple myelomaПодробнее

Overcoming T-cell exhaustion to improve CAR-T efficacy in multiple myeloma

Darzalex (daratumumab) - 2024 Updated #myelomaПодробнее

Darzalex (daratumumab) - 2024 Updated #myeloma

Immune strategies in consolidation and maintenance for multiple myelomaПодробнее

Immune strategies in consolidation and maintenance for multiple myeloma

5 Multiple Myeloma- Sidor BCBC24Подробнее

5 Multiple Myeloma- Sidor BCBC24

Sequencing CAR T-cells and bispecific antibodies in the treatment of multiple myelomaПодробнее

Sequencing CAR T-cells and bispecific antibodies in the treatment of multiple myeloma

50 MINUTES ON MULTIPLE MYELOMA (MM) - Special lectures, special GuestsПодробнее

50 MINUTES ON MULTIPLE MYELOMA (MM) - Special lectures, special Guests

Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024Подробнее

Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024

USMLE ACE Video 60: Multiple myeloma, Waldenström macroglobulinemia and MGUSПодробнее

USMLE ACE Video 60: Multiple myeloma, Waldenström macroglobulinemia and MGUS

Bispecific Antibodies in Multiple MyelomaПодробнее

Bispecific Antibodies in Multiple Myeloma

Mezigdomide, dexamethasone and tazemetostat in patients with multiple myeloma in the CA057-003 trialПодробнее

Mezigdomide, dexamethasone and tazemetostat in patients with multiple myeloma in the CA057-003 trial

Triplet regimens for treating multiple myeloma at early relapseПодробнее

Triplet regimens for treating multiple myeloma at early relapse

Dexamethasone - Uses, Mechanism Of Action, Pharmacology, Adverse Effects & ContraindicationsПодробнее

Dexamethasone - Uses, Mechanism Of Action, Pharmacology, Adverse Effects & Contraindications

Dr Krishnan on the Evolving Role of Belantamab Mafodotin in Multiple MyelomaПодробнее

Dr Krishnan on the Evolving Role of Belantamab Mafodotin in Multiple Myeloma

Relapsed/refractory multiple myeloma (RRMM): Best practices in treating early RRMMПодробнее

Relapsed/refractory multiple myeloma (RRMM): Best practices in treating early RRMM

Multiple Myeloma: Unmet medical needs in early relapseПодробнее

Multiple Myeloma: Unmet medical needs in early relapse

Multiple Myeloma: What is it, And Can It Ever Be Cured?Подробнее

Multiple Myeloma: What is it, And Can It Ever Be Cured?

Selecting therapeutics for treating early relapses in multiple myelomaПодробнее

Selecting therapeutics for treating early relapses in multiple myeloma

The evolving use of selinexor in multiple myelomaПодробнее

The evolving use of selinexor in multiple myeloma

Relapsed/refractory multiple myeloma (RRMM): The relevance of adding a new MoAПодробнее

Relapsed/refractory multiple myeloma (RRMM): The relevance of adding a new MoA